Modular Medical Announces Addition To The Russell Microcap Index, Effective When The Market Opens On July 1, 2024.

6/3/24 8:17:11 AM ET

Medical/Dental Instruments

Health Care

Get the next $MODD alert in real time by email

Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that it is set to join the Russell Microcap Index at the conclusion of the 2024 Russell indexes annual reconstitution, effective when the U.S. market opens on July 1, 2024.

Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.

Get the next $MODD alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MODD

Date	Price Target	Rating	Analyst

More analyst ratings

Modular Medical Announces Pricing of $8.2 Million Public Offering
SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced that it has priced an underwritten public offering (the "offering") of 5,450,573 shares of its common stock. The offering was led by existing institutional investors, including Manchester Explorer, L.P., which is the largest shareholder of the Company and is managed by Jeb Besser, Modular Medical's Chief Executive Officer. The shares of common stock are being sold at a price t
11/21/24 9:15:00 PM ET
$MODD
Medical/Dental Instruments
Health Care
Modular Medical Announces Proposed Public Offering
SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced that it has commenced an underwritten public offering (the "offering") of shares of its common stock (or pre-funded warrants to purchase shares of its common stock in lieu thereof). Modular Medical also has granted the underwriter a 30-day option to purchase up to an additional 15% of the aggregate number of shares of its common stock (or pre-funded warrants) sold in the offering. The offering
11/21/24 4:05:00 PM ET
$MODD
Medical/Dental Instruments
Health Care
Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference
SAN DIEGO, CA / ACCESSWIRE / November 11, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced that it is a Gold sponsor of the upcoming, first annual Achieving Diabetes Equity in Practice Today (ADEPT) Conference taking place at the Chicago Marriott Downtown on November 12 and 13,2024. The ADEPT Conference, which is the result of a collaborative effort between the American Diabetes Association and the T1D Exchange, will bring together key stakeholders focused on achiev
11/11/24 8:00:00 AM ET
$MODD
Medical/Dental Instruments
Health Care

Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump
SAN DIEGO, CA / ACCESSWIRE / September 4, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery system technology company preparing to launch a market expansion product with a more accessible, easier to prescribe, and easier to pay for and live with technology, today announced it will hold a conference call and webcast tomorrow, Thursday, September 5, 2024, at 8:30 a.m. Eastern Time to discuss the U. S. Food and Drug Administration ("FDA") clearance of its MODD1 pump, as well as next steps and milestones.Conference Call and Webcast InformationDate: September 5, 2024Time: 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time)Conference Call Number: 1-88
9/4/24 6:57:00 PM ET
$MODD
Medical/Dental Instruments
Health Care
Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump
MODD1 is a patch pump for ALL adults with Type 1 and Type 2 diabetesDesigned to be simpler and more affordable to expand access to diabetes technology for previously underserved communitiesCommercial availability expected in early 2025 SAN DIEGO, CA / ACCESSWIRE / September 4, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery system technology company preparing to launch a market expansion product with a more accessible, easier to prescribe, and easier to pay for and live with technology, today announced it has received U. S. Food and Drug Administration ("FDA") clearance to market and sell its MODD1 pump in the United States. With its comme
9/4/24 4:30:00 PM ET
$MODD
Medical/Dental Instruments
Health Care
Modular Medical Announces 510(k) Submission of MODD1 Insulin Pump
SAN DIEGO, CA / ACCESSWIRE / January 19, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced the premarket submission of its MODD1 next-generation insulin pump to the FDA for 510(k) clearance."This is an exciting milestone for the Company, as we seek to change the diabetes market. Almost 30 years after the introduction of the first insulin pump, more than three quarters of those who could benefit from wearing a pump do not wear one. It is our belief that our simplified design will encourage many "a
1/19/24 6:00:00 AM ET
$MODD
Medical/Dental Instruments
Health Care

Modular Medical Announces Addition to the Russell Microcap(R) Index
SAN DIEGO, CA / ACCESSWIRE / June 3, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that it is set to join the Russell Microcap Index at the conclusion of the 2024 Russell indexes annual reconstitution, effective when the U.S. market opens on July 1, 2024.Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalizatio
6/3/24 8:00:00 AM ET
$MODD
Medical/Dental Instruments
Health Care
Modular Medical Announces Diabetes Industry Veteran Duane DeSisto Will Join the Board of Directors
SAN DIEGO, CA / ACCESSWIRE / July 6, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced the appointment of medical device industry leader Duane DeSisto to its board of directors. Mr. DeSisto was previously President, CEO and Director of Insulet Corporation, developers of the groundbreaking OmniPod Insulin Management System, before retiring in 2014."Duane brings more than 25 years of experience in the medical device industry and is a visionary business leader credited with the launch and transformatio
7/6/23 8:30:00 AM ET
$MODD
Medical/Dental Instruments
Health Care
Modular Medical Appoints Kevin Schmid as Chief Operating Officer
Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturingSAN DIEGO, CA / ACCESSWIRE / July 26, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical")(NASDAQ:MODD) today announced that it has appointed industry veteran Kevin Schmid as its Chief Operating Officer. Mr. Schmid brings extensive operations and business development leadership experience in diabetes and drug delivery. As Vice President of Operations and Business Development at Insulet Corporation, he was instrumental in the development, manufacturing, and commercialization of wearable smart drug delivery pumps such as the Omnipod Diabete
7/26/22 8:15:00 AM ET
$MODD
Medical/Dental Instruments
Health Care

Modular Medical Announces Addition To The Russell Microcap Index, Effective When The Market Opens On July 1, 2024.
Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that it is set to join the Russell Microcap Index at the conclusion of the 2024 Russell indexes annual reconstitution, effective when the U.S. market opens on July 1, 2024.Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
6/3/24 8:17:11 AM ET
$MODD
Medical/Dental Instruments
Health Care
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Aesthetic Medical Intl (NASDAQ:AIH) shares moved upwards by 23.3% to $0.57 during Monday's after-market session. The market value of their outstanding shares is at $27.0 million. Harrow (NASDAQ:HROW) shares rose 13.5% to $13.7. The market value of their outstanding shares is at $484.7 million. As per the press release, Q1 earnings came out today. Vaxart (NASDAQ:VXRT) stock moved upwards by 12.19% to $0.92. The market value of their outstanding shares is at $162.6 million. The company's, Q1 earnings came out today. Modular Medical (NASDAQ:MODD) shares moved upwards by 7.77% to $1.94. The market value of their outstanding shares is at $60.1 million. Gossamer Bio (NASDAQ:GOSS) stoc
5/13/24 4:31:07 PM ET
$AIH
$AKYA
$AUGX
$CLDI
Medical Specialities
Health Care
Biotechnology: Laboratory Analytical Instruments
Industrials
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Avalo Therapeutics (NASDAQ:AVTX) shares moved upwards by 215.8% to $15.0 during Wednesday's after-market session. The market value of their outstanding shares is at $12.0 million. Fresh2 Group (NASDAQ:FRES) stock moved upwards by 5.26% to $0.6. The company's market cap stands at $14.2 million. Biora Therapeutics (NASDAQ:BIOR) shares rose 5.12% to $1.23. The company's market cap stands at $33.4 million. As per the news, the Q4 earnings report came out yesterday. Athira Pharma (NASDAQ:ATHA) stock rose 5.07% to $2.69. The market value of their outstanding shares is at $103.0 million. Clearside Biomedical (NASDAQ:CLSD) stock rose 4.79% to $1.75. The company's market cap stands at $1
3/27/24 4:31:13 PM ET
$ALZN
$ATHA
$AVTX
$BIOR
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Biological Products (No Diagnostic Substances)
Medical Specialities

Modular Medical Announces Addition To The Russell Microcap Index, Effective When The Market Opens On July 1, 2024.

Chat with this insight

Recent Analyst Ratings for $MODD

$MODD Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Manchester Management Co Llc bought $990,000 worth of shares (900,000 units at $1.10) (SEC Form 4)

Sheibley Philip Brent bought $12,900 worth of shares (10,000 units at $1.29), increasing direct ownership by 28% to 46,139 units (SEC Form 4)

Manchester Management Co Llc bought $35,523 worth of shares (33,000 units at $1.08) (SEC Form 4)

$MODD Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Volkart Carmen B was granted 625 shares, increasing direct ownership by 6% to 10,835 units (SEC Form 4)

SEC Form 4 filed by Director Vos Ellen O'Connor

SEC Form 4 filed by Director Sheibley Philip Brent

$MODD SEC Filings

$MODD Press Releases

Fastest customizable press release news feed in the world

$MODD Financials

Live finance-specific insights

$MODD Leadership Updates

Live Leadership Updates

SEC Form 424B5 filed by Modular Medical Inc.

SEC Form 10-Q filed by Modular Medical Inc.

Modular Medical Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

Modular Medical Announces Pricing of $8.2 Million Public Offering

Modular Medical Announces Proposed Public Offering

Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference

Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump

Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump

Modular Medical Announces 510(k) Submission of MODD1 Insulin Pump

Modular Medical Announces Addition to the Russell Microcap(R) Index

Modular Medical Announces Diabetes Industry Veteran Duane DeSisto Will Join the Board of Directors

Modular Medical Appoints Kevin Schmid as Chief Operating Officer

$MODD Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Modular Medical Inc.

SEC Form SC 13D/A filed by Modular Medical Inc. (Amendment)

SEC Form SC 13G/A filed by Modular Medical Inc. (Amendment)

$MODD Market Insights

Live Market Insights

Modular Medical Announces Addition To The Russell Microcap Index, Effective When The Market Opens On July 1, 2024.

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

Recent Analyst Ratings for
$MODD

$MODD
Insider Purchases

$MODD
Insider Trading

$MODD
SEC Filings

$MODD
Press Releases

$MODD
Financials

$MODD
Leadership Updates

$MODD
Large Ownership Changes

$MODD
Market Insights